Sign In
NASDAQ:IRMD
iRadimed Corporation Stock Earnings Reports
$51.77
-0.190 (-0.366%)
At Close: Apr 17, 2025
iRadimed Earnings Calls
Q1 2025
(Upcoming)
| Release date | May 01, 2025 |
| EPS estimate | $0.430 |
| EPS actual | - |
| Revenue estimate | 19.332M |
| Revenue actual | - |
| Expected change | +/- 11.26% |
Q4 2024
Missed
$0.440 (-2.22%)
| Release date | Feb 13, 2025 |
| EPS estimate | $0.450 |
| EPS actual | $0.440 |
| EPS Surprise | -2.22% |
| Revenue estimate | 19.2M |
| Revenue actual | 19.389M |
| Revenue Surprise | 0.99% |
Q3 2024
Beat
$0.430 (10.26%)
| Release date | Oct 31, 2024 |
| EPS estimate | $0.390 |
| EPS actual | $0.430 |
| EPS Surprise | 10.26% |
| Revenue estimate | 18.94M |
| Revenue actual | 18.326M |
| Revenue Surprise | -3.24% |
Q2 2024
Beat
$0.420 (13.51%)
| Release date | Aug 01, 2024 |
| EPS estimate | $0.370 |
| EPS actual | $0.420 |
| EPS Surprise | 13.51% |
| Revenue estimate | 17.65M |
| Revenue actual | 17.929M |
| Revenue Surprise | 1.58% |
Last 4 Quarters for iRadimed
Below you can see how IRMD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q2 2024
Beat
| Release date | Aug 01, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $46.15 |
| EPS estimate | $0.370 |
| EPS actual | $0.420 |
| EPS surprise | 13.51% |
| Date | Price |
|---|---|
| Jul 26, 2024 | $47.51 |
| Jul 29, 2024 | $46.72 |
| Jul 30, 2024 | $46.42 |
| Jul 31, 2024 | $46.71 |
| Aug 01, 2024 | $46.15 |
| Aug 02, 2024 | $44.40 |
| Aug 05, 2024 | $44.26 |
| Aug 06, 2024 | $43.64 |
| Aug 07, 2024 | $43.23 |
| 4 days before | -2.86% |
| 4 days after | -6.33% |
| On release day | -3.79% |
| Change in period | -9.01% |
Q3 2024
Beat
| Release date | Oct 31, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $49.27 |
| EPS estimate | $0.390 |
| EPS actual | $0.430 |
| EPS surprise | 10.26% |
| Date | Price |
|---|---|
| Oct 25, 2024 | $50.39 |
| Oct 28, 2024 | $52.03 |
| Oct 29, 2024 | $52.55 |
| Oct 30, 2024 | $52.94 |
| Oct 31, 2024 | $49.27 |
| Nov 01, 2024 | $48.30 |
| Nov 04, 2024 | $49.36 |
| Nov 05, 2024 | $52.74 |
| Nov 06, 2024 | $56.20 |
| 4 days before | -2.22% |
| 4 days after | 14.07% |
| On release day | -1.97% |
| Change in period | 11.53% |
Q4 2024
Missed
| Release date | Feb 13, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $55.41 |
| EPS estimate | $0.450 |
| EPS actual | $0.440 |
| EPS surprise | -2.22% |
| Date | Price |
|---|---|
| Feb 07, 2025 | $60.15 |
| Feb 10, 2025 | $60.22 |
| Feb 11, 2025 | $61.18 |
| Feb 12, 2025 | $60.48 |
| Feb 13, 2025 | $55.41 |
| Feb 14, 2025 | $55.23 |
| Feb 18, 2025 | $56.97 |
| Feb 19, 2025 | $56.74 |
| Feb 20, 2025 | $57.14 |
| 4 days before | -7.89% |
| 4 days after | 3.13% |
| On release day | -0.316% |
| Change in period | -5.00% |
Q1 2025
(Upcoming)
| Release date | May 01, 2025 |
| Fiscal end date | Mar 30, 2025 |
| Price on release | - |
| EPS estimate | $0.430 |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 11, 2025 | $52.29 |
| Apr 14, 2025 | $53.03 |
| Apr 15, 2025 | $51.96 |
| Apr 16, 2025 | $51.96 |
| Apr 17, 2025 | $51.77 |
iRadimed Earnings Call Transcript Summary of Q4 2024
- International sales saw a decrease of 24.
Product Development Updates
- The new 3870 MR IV pump is progressing through the FDA clearance process, with expectations for clearance by mid-summer 2025.
iRadimed Earnings History
Earnings Calendar
FAQ
When is the earnings report for IRMD?
iRadimed Corporation (IRMD) has scheduled its earnings report for May 01, 2025 before the markets open.
What is the IRMD price-to-earnings (P/E) ratio?
IRMD P/E ratio as of Apr 17, 2025 (TTM) is 34.26.
What is the IRMD EPS forecast?
The forecasted EPS (Earnings Per Share) for iRadimed Corporation (IRMD) for the first fiscal quarter 2025 is $0.430.
What are iRadimed Corporation's retained earnings?
On its balance sheet, iRadimed Corporation reported retained earnings of $19.39 million for the latest quarter ending Dec 31, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
